Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/9f624ec8-7f0d-4567-8a31-1e86b12a36dd/

M3V

MeVis Medical Solutions AG
Chart
€23.20
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.74
OS Score
61.0%
Value
84.0%
Quality
31.0%
Momentum
6/9
F-Score
0.716
QV
Strategy Eligibility
5 of 23 passing
OS Composite
Trending Value
Quality × Value
QV 0.716
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
P/E 13.3
VC2 Cheapest
📐
EBITDA/EV
8.9%
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
10.8%
💰
High Yield
Div 10.8%
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
61.0%ile
P/E
13.3×
P/S
2.6×
P/B
2.4×
E/P
0.0750
FCF Yield
0.097
EBITDA/EV
0.089
SH Yield
0.108
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
60.00000000
/100 — 1=cheapest
VC2 (Trending Value)
36.00000000
/100
VC3 (Buyback)
38.00000000
/100
FCF yield of 9.7% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
84.0%ile
ROE
0.178
ROA
0.137
Net Margin
0.197
Op Margin
0.146
GPA
0.677
Current
2.27
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.054
Earn Growth
-0.306
Accruals
-0.031
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
31.0%ile
6M Return
-2.9%
12M Return
-4.5%
12-1 Mom
-4.5%
Risk-Adj
-0.23
Vol 252d
19.1%
Vol 60d
47.7%
↑ Expanding
Max DD 12M
-12.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (48%) is expanding vs long-term (19%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.74
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 79 peers
Sector Value %ile
76.2%
Sector Quality %ile
76.2%
P/E z-score
-0.59
P/B z-score
-0.32
Sector Avg OS
49.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
MED MEDICLIN Aktiengesellschaft 99.0% 97.0% 83.0% 79.0%
DRW8 Drägerwerk AG & Co. KGaA 96.0% 93.0% 62.0% 78.0%
AJ91 DocCheck AG 95.0% 82.0% 88.0% 70.0%
DRW3 Drägerwerk AG & Co. KGaA 95.0% 85.0% 62.0% 80.0%
CBHD Coloplast A/S 94.0% 98.0% 91.0% 22.0%
M12 M1 Kliniken AG 93.0% 70.0% 89.0% 76.0%
BRM Bristol-Myers Squibb Company 92.0% 61.0% 98.0% 74.0%
NOV Novo Nordisk A/S 91.0% 98.0% 78.0% 20.0%
Factor Interactions
Strong Capital Return
Shareholder yield 10.8% backed by 9.7% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (48%) significantly exceeds 252-day (19%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
74.1% avg (7 factors)
Quality
B
71.5% avg (7 factors)
Momentum
F
27.2% avg (4 factors)
Risk
A
84.8% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.740—1
Value %ile0.610—0
Quality %ile0.840—1
Momentum %ile0.310—0
F-Score6.000—0
Confidence0.879—1
Volatility0.191—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
13.34
Earnings Yield (E/P)
0.0750
Price / Sales
2.63
Price / Book
2.37
Price / Cash Flow
10.89
FCF Yield
9.7%
EBITDA / EV
8.9%
Sales Yield (1/P·S)
0.4164
Shareholder Yield
Div + net buyback / mktcap
10.8%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
17.8%
Return on Assets
13.7%
Net Margin
19.7%
Operating Margin
14.6%
Gross Profit / Assets
Novy-Marx GPA
67.7%
Current Ratio
2.27
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.031
MomentumPrice trend strength over different horizons
6M Return
-2.9%
12M Return
-4.5%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-4.5%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.23
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-5.4%
Earnings Growth (YoY)
-30.6%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
10.8%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
60
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
36
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
38
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity